Tag: Israel
-
Bayer, Compugen to Partner on Cancer Immunotherapies
The pharmaceutical company Bayer HealthCare in Berlin and drug discovery company Compugen Ltd in Tel Aviv, Israel agreed on a development and licensing deal for two potential cancer therapies discovered by Compugen that harness the body’s immune system. The deal has a potential value to Compugen of at least $540 million. Compugen uses computational biology,…
-
Electronic Skin Material Devised to Detect Multiple Senses
Chemical engineers at Technion-Israel Institute of Technology developed a flexible sensor that can simultaneously detect touch, humidity, and temperature. The team led by Technion’s Hossam Haick published its findings in the June issue of the journal ACS Applied Materials & Interfaces (paid subscription required). The Technion team aimed to develop a flexible electronic sensor that would…
-
FDA Designates Orphan Drug for Rare Pain Condition
The U.S. Food and Drug Administration designated as an orphan drug the compound XEN402 to treat erythromelalgia, a rare disease that causes a burning pain in the feet and hands. XEN402 is being developed Xenon Pharmaceuticals in Burnaby, British Columbia, Canada. Erythromelalgia is a disorder that affects the skin of the feet or hands or…
-
Biotech Wins Fox Grant for Parkinson’s Drug Delivery Test
Intec Pharma, a biotechnology company in Jerusalem, Israel, received a $705,000 grant from the Michael J. Fox Foundation for a clinical trial of its system to deliver the drug combination carbidopa and levodopa to treat Parkinson’s disease. The company expects to complete the test in the first quarter of 2014. Intec Pharma developed an oral…
-
Portable White Blood Cell Measurement Device Developed
Engineers at California Institute of Technology in Pasadena and the medical device company LeukoDx in Jerusalem, Israel developed a portable device to count white blood cells requiring only a drop of blood and a few minutes to run. The team led by Cal Tech electrical engineering professor Yu-Chong Tai published its findings in the 7…
-
Roche, Biotech to Partner on Growth Hormone Disorders
The Swiss pharmaceutical company Roche will license a compound developed by biotechnology company Chiasma Inc., based in New York and Jerusalem, to treat the hormonal disease acromegaly and neuroendocrine tumors. The deal has a total potential value to Chiasma of $595 million. Chiasma develops drugs for oral administration previously available in injection form. The company’s…
-
Industrial Process Devised for Carbon Nanotube Fibers
Engineers and materials scientists from the U.S., Netherlands, and Israel developed an industrial-scale process for spinning carbon nanotubes into fibers for a range of commercial products. The team led by chemical engineering professor Matteo Pasquali at Rice University in Houston published its findings in this week’s issue of the journal Science (paid subscription required). Pasquali,…
-
Collaboration to Build Three New Pediatric Medical Devices
A partnership between Cincinnati Children’s Hospital in Ohio and Ben-Gurion University of the Negev in Israel will develop three new medical devices designed to meet children’s medical needs. The collaboration that combines Cincinnati Children’s Hospital’s clinical staff with engineers from Ben-Gurion was first announced last May to help address unmet needs for pediatric medical devices,…
-
U.S. Patent Awarded for Protein Therapy Delivery Technology
Medgenics Inc., a biotechnology company in Misgav, Israel and San Francisco, received a U.S. patent for its technology for the sustained delivery of therapeutic proteins to treat anemia. Patent number 8,293,463 was awarded by the U.S. Patent and Trademark Office on 23 October 2012 to 11 inventors, including Andrew Pearlman, president of Medgenics Inc., and…
-
Computer Chips Recast for High Frequency Detector Circuits
Engineers at Tel Aviv University in Israel reconfigured common computer chips into high frequency circuits, making them useful for building low-cost security imaging devices. Eran Socher, a lecturer in Tel Aviv’s engineering department, is leading the university’s research team that published its findings in a recent issue of the journal IEEE Microwave and Wireless Components…